Home Page View Cart

ban_about.gif

US Patent Allowance Awarded, 2001

US Patent Allowance Awarded for Innovation of Homeopathic Recombinant Human Growth Hormone
February 13, 2001 --Biomed Comm® Inc.,
Seattle WA.

Biomed Comm,® Inc, innovators of Cell Signal Enhancers®, received notice from the US Patent and Trademark Office of allowance on claims for its innovation entitled “ Homeopathic Preparations of Purified Growth Hormone”. This composition patent of purified growth hormone, includes recombinant human growth hormone (rhGH), and methods of use at a broad range of molar concentrations and homeopathic dilutions, including combination potency formulations. Biomed Comm® holds the first of it’s kind broad patent entitled “Homeopathic Dilutions of Growth Factors” that includes homeopathic forms of growth hormone. Homeopathic rhGH is clinically proven to improve body functioning including: reduce body fat, increase lean body mass, restore energy and improve sleep patterns, plus increase psychological health.

Biomed Comm,® Inc., a Seattle based biotechnology company, researches, develops and markets clinically proven safe, pure, affordable, well-characterized homeopathic drugs. Their line of over the counter homeopathic Cell Signal Enhancers® are believed to facilitate cell to cell communication so critical to overall health and well being.

"This innovation represents an advance in integrative medicine, combining biotechnology’s well-characterized USP proteins and traditional non-toxic principles of homeopathy. These newly patented products are available to people seeking reliable, clinically effective and USP standardized homeopathic drugs to improve their health and quality of life physically and psychologically without a prescription," said Barbara Brewitt, CEO and Chief Scientific Officer.

This new patent allows specific claims associated with highly purified homeopathic rhGH for a variety of over-the-counter medicinal and unique cosmetic applications. Homeopathic rhGH cited in the patent guarantee consumers the purest possible formulas, from FDA approved sources, using no bovine or animal sources.

This patent comprises intellectual property giving Biomed Comm® the right to exclude unauthorized competitors from selling homeopathic rhGH over-the-counter. Biomed Comm’s® intellectual property is supported by it’s extensive research and clinical studies. This is the fourth U.S. patent exclusively licensed by Biomed Comm,® Inc. in effort to protect consumer’s well-being against substandard products and unfounded claims.

 


hGH